Annual Congress Vienna 2012

Saturday, 01.09.2012
Sunday, 02.09.2012
Monday, 03.09.2012
Tuesday, 04.09.2012
Wednesday, 05.09.2012

Citations should be made in the following way: Authors. Title. Eur Respir J 2012; 40: Suppl. 56, abstract number.



Award for Achievement in the field of NSCLC Ceremony (supported by AstraZeneca) followed by Grand Round "How to diagnose and manage NSCLC with the new drugs" - an interactive session

Grand round
Chairs: J. Cadranel (Paris, France), J-P. Sculier (Brussels, Belgium)
Aims: The therapeutic management of advanced NSCLC underwent a therapeutic revolution in recent years. The use of TKI specific to addictive molecular abnormalities (EGFR mutations, ALK translocation) in patients whose tumours carried such mutations has been associated with major and prolonged objective response. The use of platinum-based doublets, and especially the development of maintenance strategies, also provide therapeutic benefit in overall survival. It is important that pulmonologists and oncolo-pneumologists can integrate this data into their clinical practice. The aim of this session will be to illustrate by exemplary clinical cases the diagnostic approach of addictive mutations, the practical use of TKI, what to do in case of toxicities and progression, and finally to address the concepts of the continuation maintenance or switch maintenance.
Introduction of the 2012 Award for Achievement in the field of Nonsmall Cell Lung Carcinoma
J-P. Sculier (Brussels, Belgium)
Multimedia files
Multimedia files
To continue, to switch or just following up?
M. Dediu (Bucharest, Romania)
Slide presentationMultimedia files
Slide presentationMultimedia files
A woman with addiction
L. Landi (Livorno, Italy)
Slide presentationMultimedia files
Slide presentationMultimedia files
A man who was sick because of signet rings
D. Moro Sibilot (Grenoble, France)
Slide presentationMultimedia files
Slide presentationMultimedia files